Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia.

Puranen A, Koponen M, Tanskanen A, Tiihonen J, Taipale H.

Eur J Clin Pharmacol. 2020 Jan 15. doi: 10.1007/s00228-020-02830-2. [Epub ahead of print]

PMID:
31940085
2.

Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.

Lampela P, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H.

J Alzheimers Dis. 2020;73(3):1243-1251. doi: 10.3233/JAD-190850.

PMID:
31929157
3.

The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.

Tapiainen V, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

J Am Geriatr Soc. 2020 Jan 7. doi: 10.1111/jgs.16275. [Epub ahead of print]

PMID:
31912482
4.

Right Ventricle Rupture After Open Heart Surgery.

Weyrauch D, Kemp WL, Koponen M.

Am J Forensic Med Pathol. 2020 Mar;41(1):35-39. doi: 10.1097/PAF.0000000000000523.

PMID:
31876539
5.

Trajectory Analyses of Adherence Patterns in a Real-Life Moderate to Severe Asthma Population.

van Boven JFM, Koponen M, Lalic S, George J, Bell JS, Hew M, Ilomaki J.

J Allergy Clin Immunol Pract. 2019 Dec 16. pii: S2213-2198(19)31022-0. doi: 10.1016/j.jaip.2019.12.002. [Epub ahead of print]

PMID:
31857262
6.

Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.

Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen AM.

Int J Cardiol. 2020 Feb 1;300:221-225. doi: 10.1016/j.ijcard.2019.09.036. Epub 2019 Oct 30.

PMID:
31810814
7.

Metformin and risk of Alzheimer's disease among community-dwelling people with diabetes: a national case-control study.

Sluggett JK, Koponen M, Bell JS, Taipale H, Tanskanen A, Tiihonen J, Uusitupa M, Tolppanen AM, Hartikainen S.

J Clin Endocrinol Metab. 2019 Nov 28. pii: dgz234. doi: 10.1210/clinem/dgz234. [Epub ahead of print]

PMID:
31778170
8.

Maternal use of drugs and preeclampsia.

Sahlman H, Koponen M, El-Nezami H, Vähäkangas K, Keski-Nisula L.

Br J Clin Pharmacol. 2019 Dec;85(12):2848-2855. doi: 10.1111/bcp.14117. Epub 2019 Dec 15.

PMID:
31691323
9.

Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease.

Koponen M, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

J Am Med Dir Assoc. 2019 Dec;20(12):1488-1494.e3. doi: 10.1016/j.jamda.2019.07.009. Epub 2019 Aug 26.

10.

Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.

Taipale H, Rysä J, Hukkanen J, Koponen M, Tanskanen A, Tiihonen J, Kröger H, Hartikainen S, Tolppanen AM.

Osteoporos Int. 2019 Jul;30(7):1481-1489. doi: 10.1007/s00198-019-04957-0. Epub 2019 Apr 16.

11.

Forensic Autopsy Experience and Core Entrustable Professional Activities: A Structured Introduction to Autopsy Pathology for Preclinical Student.

Kemp WL, Koponen M, Sens MA.

Acad Pathol. 2019 Mar 5;6:2374289519831930. doi: 10.1177/2374289519831930. eCollection 2019 Jan-Dec.

12.

Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.

Taipale H, Lampela P, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

J Alzheimers Dis. 2019;68(1):127-136. doi: 10.3233/JAD-180912.

13.

Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease.

Lavikainen P, Taipale H, Tanskanen A, Koponen M, Tiihonen J, Hartikainen S, Tolppanen AM.

J Am Med Dir Assoc. 2019 Jun;20(6):751-758. doi: 10.1016/j.jamda.2018.11.012. Epub 2019 Jan 7.

14.

Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease.

Kettunen R, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Koponen M.

Eur J Clin Pharmacol. 2019 Mar;75(3):417-425. doi: 10.1007/s00228-018-2591-5. Epub 2018 Nov 9.

PMID:
30413841
15.

Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study.

Taipale H, Hamina A, Karttunen N, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM.

Pain. 2019 Feb;160(2):417-423. doi: 10.1097/j.pain.0000000000001412.

PMID:
30325873
16.

Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.

Tolppanen AM, Tiihonen M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tiihonen J, Hartikainen S.

Drugs Aging. 2018 Nov;35(11):985-992. doi: 10.1007/s40266-018-0591-x.

17.

Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.

Orsel K, Taipale H, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S.

Eur Neuropsychopharmacol. 2018 Nov;28(11):1260-1269. doi: 10.1016/j.euroneuro.2018.04.005. Epub 2018 Aug 25.

PMID:
30153953
18.

Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study.

Orsel K, Taipale H, Raatikainen S, Lampela P, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S.

J Clin Psychopharmacol. 2018 Oct;38(5):494-497. doi: 10.1097/JCP.0000000000000928.

PMID:
30102630
19.

Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.

Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen AM, Hartikainen S.

J Alzheimers Dis. 2018;64(2):437-445. doi: 10.3233/JAD-180125.

PMID:
29914029
20.

Editorial: let's take a break from studying the PPI-fracture association-Authors' reply.

Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H.

Aliment Pharmacol Ther. 2018 Jun;47(11):1544-1545. doi: 10.1111/apt.14666. No abstract available.

21.

Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.

Koponen M, Havulinna AS, Marjamaa A, Tuiskula AM, Salomaa V, Laitinen-Forsblom PJ, Piippo K, Toivonen L, Kontula K, Viitasalo M, Swan H.

BMC Med Genet. 2018 Apr 5;19(1):56. doi: 10.1186/s12881-018-0574-0.

22.

Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study.

Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H.

Aliment Pharmacol Ther. 2018 Apr;47(8):1135-1142. doi: 10.1111/apt.14589. Epub 2018 Mar 6.

23.

Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.

Saarelainen L, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H.

Int J Geriatr Psychiatry. 2018 Apr;33(4):583-590. doi: 10.1002/gps.4821. Epub 2017 Nov 15.

PMID:
29143367
24.

Drug exposure in register-based research-An expert-opinion based evaluation of methods.

Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J.

PLoS One. 2017 Sep 8;12(9):e0184070. doi: 10.1371/journal.pone.0184070. eCollection 2017.

25.

Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.

Taipale H, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Tolppanen AM.

Alzheimers Res Ther. 2017 Aug 1;9(1):59. doi: 10.1186/s13195-017-0285-3.

26.

Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease.

Tolppanen AM, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):875-889. doi: 10.1002/pds.4232. Epub 2017 May 29.

PMID:
28556303
27.

Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease.

Taipale H, Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S.

CMAJ. 2017 Apr 10;189(14):E519-E529. doi: 10.1503/cmaj.160126.

28.

Trends in occupational hygiene in Finland.

Pääkkönen R, Koponen M.

Int J Occup Saf Ergon. 2018 Mar;24(1):160-163. doi: 10.1080/10803548.2017.1311057. Epub 2017 Apr 13.

PMID:
28335689
29.

Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011.

Tolppanen AM, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S.

PLoS One. 2017 Mar 9;12(3):e0173450. doi: 10.1371/journal.pone.0173450. eCollection 2017.

30.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

PMID:
28146612
31.

Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.

Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tolppanen AM, Sund R, Tiihonen J, Hartikainen S.

Int Clin Psychopharmacol. 2017 May;32(3):135-141. doi: 10.1097/YIC.0000000000000161.

PMID:
28072593
32.

Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.

Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H.

Int J Geriatr Psychiatry. 2017 Dec;32(12):e107-e115. doi: 10.1002/gps.4667. Epub 2017 Jan 5.

PMID:
28055139
33.

Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Alzheimers Dis. 2017;56(1):107-118. doi: 10.3233/JAD-160671.

PMID:
27935554
34.

Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.

Saarelainen L, Tolppanen AM, Koponen M, Tanskanen A, Sund R, Tiihonen J, Hartikainen S, Taipale H.

J Am Med Dir Assoc. 2017 Jan;18(1):87.e15-87.e21. doi: 10.1016/j.jamda.2016.09.019. Epub 2016 Nov 12.

PMID:
27847263
35.

Checklist of Dinotrema Foerster, 1863 species of Finland (Hymenoptera, Braconidae, Alysiinae).

Koponen M, Peris-Felipo FJ.

Zootaxa. 2016 Oct 18;4175(6):556-570. doi: 10.11646/zootaxa.4175.6.4.

PMID:
27811740
36.

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons.

Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S.

Clin Epidemiol. 2016 Oct 11;8:363-371. eCollection 2016.

37.

Drug use in persons with and without Alzheimer's disease aged 90 years or more.

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Age Ageing. 2016 Nov;45(6):900-904. Epub 2016 Sep 8.

PMID:
27609205
38.

Is Symptomatic Long QT Syndrome Associated with Depression in Women and Men?

Wesołowska K, Elovainio M, Koponen M, Tuiskula AM, Hintsanen M, Keltikangas-Järvinen L, Määttänen I, Swan H, Hintsa T.

J Genet Couns. 2017 Jun;26(3):491-500. doi: 10.1007/s10897-016-0004-4. Epub 2016 Aug 23.

PMID:
27553078
39.

Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.

Tolppanen AM, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S.

BMJ Open. 2016 Jul 13;6(7):e012100. doi: 10.1136/bmjopen-2016-012100.

40.

Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.

Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Taipale H.

Chest. 2016 Dec;150(6):1233-1241. doi: 10.1016/j.chest.2016.06.004. Epub 2016 Jun 11.

PMID:
27298071
41.

Addison Disease: The First Presentation of the Condition May be at Autopsy.

Kemp WL, Koponen MA, Meyers SE.

Acad Forensic Pathol. 2016 Jun;6(2):249-257. doi: 10.23907/2016.026. Epub 2016 Jun 1. Review.

42.

Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study.

Tolppanen AM, Ahonen R, Koponen M, Lavikainen P, Purhonen M, Taipale H, Tanskanen A, Tiihonen J, Tiihonen M, Hartikainen S.

J Prev Med Public Health. 2016 Mar;49(2):134-8. doi: 10.3961/jpmph.16.018. Epub 2016 Mar 23.

43.

Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.

Puranen A, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Int J Geriatr Psychiatry. 2017 Jan;32(1):94-101. doi: 10.1002/gps.4450. Epub 2016 Feb 28.

PMID:
26924266
44.

The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease.

Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

J Alzheimers Dis. 2016;49(3):809-18. doi: 10.3233/JAD-150630.

PMID:
26484930
45.

Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.

Taipale H, Vuorikari H, Tanskanen A, Koponen M, Tiihonen J, Kettunen R, Hartikainen S.

Drugs Aging. 2015 Nov;32(11):937-45. doi: 10.1007/s40266-015-0316-3.

PMID:
26476844
46.

Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons.

Koponen M, Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Johnell K, Fastbom J, Ahonen R, Hartikainen S.

Br J Psychiatry. 2015 Nov;207(5):444-9. doi: 10.1192/bjp.bp.114.162834. Epub 2015 Oct 8.

PMID:
26450581
47.

Prevalence of Analgesic Use and Pain in People with and without Dementia or Cognitive Impairment in Aged Care Facilities: A Systematic Review and Meta-Analysis.

Tan EC, Jokanovic N, Koponen MP, Thomas D, Hilmer SN, Bell JS.

Curr Clin Pharmacol. 2015;10(3):194-203. Review.

PMID:
26338172
48.

Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.

Koponen M, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Ahonen R, Hartikainen S.

Eur Neuropsychopharmacol. 2015 Oct;25(10):1706-13. doi: 10.1016/j.euroneuro.2015.07.008. Epub 2015 Jul 21.

PMID:
26233607
49.

Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.

Koponen M, Marjamaa A, Hiippala A, Happonen JM, Havulinna AS, Salomaa V, Lahtinen AM, Hintsa T, Viitasalo M, Toivonen L, Kontula K, Swan H.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):815-23. doi: 10.1161/CIRCEP.114.002654. Epub 2015 Jun 10.

PMID:
26063740
50.

Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease.

Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Int Clin Psychopharmacol. 2015 Jul;30(4):202-8. doi: 10.1097/YIC.0000000000000080.

PMID:
26011780

Supplemental Content

Loading ...
Support Center